Overview A Clinical Study Trial of Phenlarmide in China Status: Recruiting Trial end date: 2021-01-31 Target enrollment: Participant gender: Summary 1. To evaluate the tolerance and safety of FLA tablets in healthy volunteers. 2. To evaluate the pharmacokinetics of FLA tablets in healthy volunteers. 3. Provide basis for dosage setting for follow-up clinical research. Phase: Phase 1 Details Lead Sponsor: Yiling Pharmaceutical Inc.